Geneoscopy, Inc.

ST. LOUIS, MO · Founded 2019 · CIK 0001787775 · Biotech · Private

Genetic testing and analysis platform for personalized medicine insights

geneoscopy.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$58M
2 Form D · Nov 2021
58 months since last filing
Contracts
—
No federal contracts on record
Patents
15
2 granted · 13 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$7,946,190
Private capital raisedForm D · SEC$50,500,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2284EMULATE THERAPEUTICS, INC.—$12M
2285Dicerna Pharmaceuticals, Inc.—$90M
2286CytoDyn Inc.—$88M
2287Geneoscopy, Inc.—$58M
2288MarvelBiome, Inc.—$55M
2289Voyager Therapeutics—$119M
2290Precision Fermentation, Inc.—$53M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 7 related persons
  • ANDREW BARNELLDirector · Executive Officer
  • ERICA BARNELLDirector · Executive Officer
  • DREW DENNISONDirector
  • JAMES MERSELISDirector
  • BOBBY SANDAGE, JR.Director
  • NAJEEB THOMASDirector
  • MARK ZORENSKYDirector

Patents

USPTO · 2 granted of 15
  • Compositions And Methods For Immunological Testing Of Stoolapplication
  • Colorectal Cancer Screening Method And Deviceapplication
  • Detection Methodapplication
  • Detection Method Using Eukaryotic Cellsapplication
  • Detection Method Using Eukaryotic Cellsgranted
  • Detection Method For Cancer Using Rna Biomarkersgranted
  • Colorectal Cancer Screening Method And Deviceapplication
  • Detection Methodapplication
  • Colorectal Cancer Screening Method And Deviceapplication
  • Compositions And Methods For Ibd Patients Using Stool-derived Eukaryotic Nucleic Acidsapplication
  • Compositions And Methods For Immunological Testing Of Stoolapplication
  • Compositions And Methods For Immunological Testing Of Stoolapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.